EMA — authorised 19 June 2015
- Marketing authorisation holder: Daiichi Sankyo Europe GmbH
- Status: approved
EMA authorised Savaysa on 19 June 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 19 June 2015.
Daiichi Sankyo Europe GmbH holds the EU marketing authorisation.